Highlights and Quick Summary
Current Graham Number of PDL BioPharma, Inc. is 0.0 (as of December 30, 2019)
- Graham Number for the quarter ending June 29, 2020 was 0.0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Graham Number decreased by NaN%
- Annual Graham Number for 2019 was 0.0 (a NaN% decrease from previous year)
- Annual Graham Number for 2018 was 0.0 (a -100.0% decrease from previous year)
- Annual Graham Number for 2017 was 9.39 (a 47.62% increase from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.
Historical Graham Number of PDL BioPharma, Inc.Most recent Graham Numberof PDLI including historical data for past 10 years.
Interactive Chart of Graham Number of PDL BioPharma, Inc.
PDL BioPharma, Inc. Graham Number for the past 10 Years (both Annual and Quarterly)
Business Profile of PDL BioPharma, Inc.
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.